DiscoverCanadian Heart Failure SocietyRecommendations for Initiation of SGLT2i in Patients with HF and T2D
Recommendations for Initiation of SGLT2i in Patients with HF and T2D

Recommendations for Initiation of SGLT2i in Patients with HF and T2D

Update: 2022-03-07
Share

Description

In this episode presented by the Canadian Heart Failure Society (CHFS) entitled “Recommendations for Initiation of SGLT2i in Patients with HF and T2D” presented by Dr. Grace Chua, we will focus on the initiation of SGLT2i in patients with HFrEF and Type 2 Diabetes and we will review practical tips and key questions to a patient case. An on-demand version of the 30-minute episode presented on the same topic is available right now at www.imedicus.ca/hf21. To learn more about the Canadian Heart Failure Society and find out more about upcoming programs and initiatives, visit www.heartfailure.ca. We hope you enjoy this episode! 


This program was made possible through grants from Novartis and BI-Lilly Alliance. 

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Recommendations for Initiation of SGLT2i in Patients with HF and T2D

Recommendations for Initiation of SGLT2i in Patients with HF and T2D

chfs